Diabetic Retinopathy Market
Diabetic Retinopathy Market: Global Industry Analysis 2015-2021 and Opportunity Assessment 2022-2032
A recent market study published by FMI on Diabetic Retinopathy offers a global industry analysis for 2015-2021 and opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
The global Diabetic Retinopathy Market is segmented in detail tcover every aspect of the market and present complete market intelligence treaders.
By Type
Proliferative
- Non-proliferative
Anti VEGF
- Intraocular Steroid Injection
- Laser Surgery
- Vitrectomy
North America
- Asia-Pacific
- Europe
- Middle East & Africa
- Latin America
Executive Summary
The executive summary of the Diabetic Retinopathy Market includes the global market outlook, demand side trends, supply side trends and alsinclude FMI analysis and recommendations of Diabetic Retinopathy.
Chapter 01 – Market Overview
Readers can find the detailed segmentation and definition of the Diabetic Retinopathy Market in this chapter, which will help tunderstand basic information about Diabetic Retinopathy. This section alshighlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Diabetic Retinopathy Market report.
Chapter 02 – Market Background
This chapter includes detailed analysis of the product processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It alsincludes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter alscovers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) tbetter understand the market.
Chapter 03 – Global Diabetic Retinopathy Market Demand Analysis 2015-2021 and Forecast, 2022-2032
The chapter include historical market value (US$ XX Billion) analysis (2015-2021) and current and future market value (US$ 8.4Bn) and volume (5.8%) projections (2022-2032). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.
Chapter 04 – Global Diabetic Retinopathy Market - Pricing Analysis
Based on By Type, the pricing analysis chapter include regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.
Chapter 05 – Global Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032, By Type
Based on By Type, Diabetic Retinopathy Market is segmented intProliferative and Non-proliferative. This section alsoffers market attractiveness analysis based on By Type. Value forecast and Y-o-Y growth comparison will alsbe provided for above mentioned By Type.
Chapter 06 – Global Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032, By Management
Based on By Management, Diabetic Retinopathy Market is segmented intAnti VEGF, Intraocular Steroid Injection, Laser Surgery, Vitrectomy. This section alsoffers market attractiveness analysis based on By Management. Readers can alsfind value forecast and y-o-y growth comparison for all above mentioned By Management.
Chapter 07 – Global Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032, By Region
Based on By Region, Diabetic Retinopathy Market is segmented intNorth America, Asia-Pacific, Europe, Middle East & Africa, Latin America. This section alsoffers market attractiveness analysis based on By Region. Readers can alsfind value forecast and Y-o-Y growth comparison for all above mentioned By Region.
Chapter 08 – North America Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the Diabetic Retinopathy in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can alsfind regional trends, regulations, and market growth based on different segment and countries in the North America region.
Chapter 09 – Latin America Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Diabetic Retinopathy in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexicand Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Diabetic Retinopathy Market in the Latin America region.
Chapter 10 – Asia-Pacific Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Diabetic Retinopathy in the Asia-Pacific region, along with a country-wise assessment that includes the China, Japan, South Korea and Rest of Asia Pacific. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Diabetic Retinopathy Market in the regional market.
Chapter 11 – Europe Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Diabetic Retinopathy in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Diabetic Retinopathy Market in the regional market.
Chapter 12 - Middle East and Africa Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Diabetic Retinopathy in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Diabetic Retinopathy Market in the regional market.
Chapter 13 - Key Countries Diabetic Retinopathy Market Analysis 2015–2021 and Forecast 2022–2032
This chapter offers insights inthow the Diabetic Retinopathy Market is expected tgrow in major countries globally.
Chapter 14 - Market Structure Analysis- Global Assessment
This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.
Chapter 15 - Competition Deep Dive (Tentative List)
This chapter includes company overview, product portfoliof companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Bayer Healthcare, Novartis AG, Regeneron Pharmaceuticals Inc., Allergan plc, Oxurion, and others
Chapter 16 - Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base tthe information and statistics included in the Diabetic Retinopathy Market report.
Chapter 17 – Research Methodology
This chapter helps readers understand the research methodology followed tobtain various conclusions, as well as important qualitative and quantitative information, on Diabetic Retinopathy Market.
- 1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Summary of Statistics
- 1.3. Key Market Characteristics & Attributes
- 1.4. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 3. Market Risks and Trends Assessment
- 3.1. Risk Assessment
- 3.1.1. COVID-19 Crisis and Impact on Demand
- 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
- 3.1.3. Impact on Market Value (US$ Mn)
- 3.1.4. Assessment by Key Countries
- 3.1.5. Assessment by Key Market Segments
- 3.1.6. Action Points and Recommendation for Suppliers
- 3.2. Key Trends Impacting the Market
- 3.3. Formulation and Product Development Trends
- 4. Market Background and Foundation Data Points
- 4.1. Global Protective Coatings Market (US$ Mn)
- 4.2. Market Opportunity Assessment (US$ Mn)
- 4.2.1. Total Available Market
- 4.2.2. Serviceable Addressable Market
- 4.2.3. Serviceable Obtainable Market
- 4.3. Market Scenario Forecast
- 4.3.1. Demand in optimistic Scenario
- 4.3.2. Demand in Likely Scenario
- 4.3.3. Demand in Conservative Scenario
- 4.4. Investment Feasibility Analysis
- 4.4.1. Investment in Established Markets
- 4.4.1.1. In Short Term
- 4.4.1.2. In Long Term
- 4.4.2. Investment in Emerging Markets
- 4.4.2.1. In Short Term
- 4.4.2.2. In Long Term
- 4.5. Forecast Factors - Relevance & Impact
- 4.5.1. Top Companies Historical Growth
- 4.5.2. Global Protective Coatings Market Growth
- 4.5.3. Adoption Rate, By Country
- 4.6. Market Dynamics
- 4.6.1. Market Driving Factors and Impact Assessment
- 4.6.2. Prominent Market Challenges and Impact Assessment
- 4.6.3. Market Opportunities
- 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
- 5. Key Success Factors
- 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
- 5.2. Banking on with Segments High Incremental Opportunity
- 5.3. Peer Benchmarking
- 6. Global Market Demand Analysis 2015-2021 and Forecast, 2022-2032
- 6.1. Historical Market Analysis, 2015-2021
- 6.2. Current and Future Market Projections, 2022-2032
- 6.3. Y-o-Y Growth Trend Analysis
- 7. Global Market Value Analysis 2015-2021 and Forecast, 2022-2032
- 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
- 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis
- 8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Type
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Mn) Analysis By Type, 2015-2021
- 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2022-2032
- 8.3.1. Proliferative
- 8.3.2. Non-proliferative
- 8.4. Market Attractiveness Analysis By Type
- 9. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Management
- 9.1. Introduction / Key Findings
- 9.2. Historical Market Size (US$ Mn) Analysis By Management, 2015-2021
- 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Management, 2022-2032
- 9.3.1. Anti VEGF
- 9.3.2. Intraocular steroid injection
- 9.3.3. Laser surgery
- 9.3.4. Vitrectomy
- 9.4. Market Attractiveness Analysis By Management
- 10. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Region
- 10.1. Introduction
- 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
- 10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. Asia Pacific
- 10.3.5. Middle East and Africa (MEA)
- 10.4. Market Attractiveness Analysis By Region
- 11. North America Market Analysis 2015-2021 and Forecast 2022-2032
- 11.1. Introduction
- 11.2. Pricing Analysis
- 11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
- 11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 11.4.1. By Country
- 11.4.1.1. U.S.
- 11.4.1.2. Canada
- 11.4.1.3. Rest of North America
- 11.4.2. By Type
- 11.4.3. By Management
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Country
- 11.5.2. By Type
- 11.5.3. By Management
- 12. Latin America Market Analysis 2015-2021 and Forecast 2022-2032
- 12.1. Introduction
- 12.2. Pricing Analysis
- 12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
- 12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 12.4.1. By Country
- 12.4.1.1. Brazil
- 12.4.1.2. Mexico
- 12.4.1.3. Rest of Latin America
- 12.4.2. By Type
- 12.4.3. By Management
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Country
- 12.5.2. By Type
- 12.5.3. By Management
- 13. Europe Market Analysis 2015-2021 and Forecast 2022-2032
- 13.1. Introduction
- 13.2. Pricing Analysis
- 13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
- 13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 13.4.1. By Country
- 13.4.1.1. Germany
- 13.4.1.2. France
- 13.4.1.3. U.K.
- 13.4.1.4. Italy
- 13.4.1.5. Benelux
- 13.4.1.6. Nordic Countries
- 13.4.1.7. Rest of Europe
- 13.4.2. By Type
- 13.4.3. By Management
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Country
- 13.5.2. By Type
- 13.5.3. By Management
- 14. Asia Pacific Market Analysis 2015-2021 and Forecast 2022-2032
- 14.1. Introduction
- 14.2. Pricing Analysis
- 14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
- 14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 14.4.1. By Country
- 14.4.1.1. China
- 14.4.1.2. Japan
- 14.4.1.3. South Korea
- 14.4.1.4. Rest of Asia Pacific
- 14.4.2. By Type
- 14.4.3. By Management
- 14.5. Market Attractiveness Analysis
- 14.5.1. By Country
- 14.5.2. By Type
- 14.5.3. By Management
- 15. Middle East and Africa Market Analysis 2015-2021 and Forecast 2022-2032
- 15.1. Introduction
- 15.2. Pricing Analysis
- 15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
- 15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 15.4.1. By Country
- 15.4.1.1. GCC Countries
- 15.4.1.2. South Africa
- 15.4.1.3. Turkey
- 15.4.1.4. Rest of Middle East and Africa
- 15.4.2. By Type
- 15.4.3. By Management
- 15.5. Market Attractiveness Analysis
- 15.5.1. By Country
- 15.5.2. By Type
- 15.5.3. By Management
- 16. Key Countries Market Analysis 2015-2021 and Forecast 2022-2032
- 16.1. Introduction
- 16.1.1. Market Value Proportion Analysis, By Key Countries
- 16.1.2. Global Vs. Country Growth Comparison
- 16.2. US Market Analysis
- 16.2.1. Value Proportion Analysis by Market Taxonomy
- 16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.2.2.1. By Type
- 16.2.2.2. By Management
- 16.3. Canada Market Analysis
- 16.3.1. Value Proportion Analysis by Market Taxonomy
- 16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.3.2.1. By Type
- 16.3.2.2. By Management
- 16.4. Mexico Market Analysis
- 16.4.1. Value Proportion Analysis by Market Taxonomy
- 16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.4.2.1. By Type
- 16.4.2.2. By Management
- 16.5. Brazil Market Analysis
- 16.5.1. Value Proportion Analysis by Market Taxonomy
- 16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.5.2.1. By Type
- 16.5.2.2. By Management
- 16.6. Germany Market Analysis
- 16.6.1. Value Proportion Analysis by Market Taxonomy
- 16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.6.2.1. By Type
- 16.6.2.2. By Management
- 16.7. France Market Analysis
- 16.7.1. Value Proportion Analysis by Market Taxonomy
- 16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.7.2.1. By Type
- 16.7.2.2. By Management
- 16.8. Italy Market Analysis
- 16.8.1. Value Proportion Analysis by Market Taxonomy
- 16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.8.2.1. By Type
- 16.8.2.2. By Management
- 16.9. BENELUX Market Analysis
- 16.9.1. Value Proportion Analysis by Market Taxonomy
- 16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.9.2.1. By Type
- 16.9.2.2. By Management
- 16.10. UK Market Analysis
- 16.10.1. Value Proportion Analysis by Market Taxonomy
- 16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.10.2.1. By Type
- 16.10.2.2. By Management
- 16.11. Nordic Countries Market Analysis
- 16.11.1. Value Proportion Analysis by Market Taxonomy
- 16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.11.2.1. By Type
- 16.11.2.2. By Management
- 16.12. China Market Analysis
- 16.12.1. Value Proportion Analysis by Market Taxonomy
- 16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.12.2.1. By Type
- 16.12.2.2. By Management
- 16.13. Japan Market Analysis
- 16.13.1. Value Proportion Analysis by Market Taxonomy
- 16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.13.2.1. By Type
- 16.13.2.2. By Management
- 16.14. South Korea Market Analysis
- 16.14.1. Value Proportion Analysis by Market Taxonomy
- 16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.14.2.1. By Type
- 16.14.2.2. By Management
- 16.15. GCC Countries Market Analysis
- 16.15.1. Value Proportion Analysis by Market Taxonomy
- 16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.15.2.1. By Type
- 16.15.2.2. By Management
- 16.16. South Africa Market Analysis
- 16.16.1. Value Proportion Analysis by Market Taxonomy
- 16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.16.2.1. By Type
- 16.16.2.2. By Management
- 16.17. Turkey Market Analysis
- 16.17.1. Value Proportion Analysis by Market Taxonomy
- 16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.17.2.1. By Type
- 16.17.2.2. By Management
- 16.17.3. Competition Landscape and Player Concentration in the Country
- 17. Market Structure Analysis
- 17.1. Market Analysis by Tier of Companies
- 17.2. Market Concentration
- 17.3. Market Share Analysis of Top Players
- 17.4. Market Presence Analysis
- 17.4.1. By Regional footprint of Players
- 17.4.2. Product footprint by Players
- 18. Competition Analysis
- 18.1. Competition Dashboard
- 18.2. Competition Benchmarking
- 18.3. Competition Deep Dive
- 18.3.1. Bayer Healthcare
- 18.3.1.1. Overview
- 18.3.1.2. Product Portfolio
- 18.3.1.3. Sales Footprint
- 18.3.1.4. Strategy Overview
- 18.3.2. Novartis AG
- 18.3.2.1. Overview
- 18.3.2.2. Product Portfolio
- 18.3.2.3. Sales Footprint
- 18.3.2.4. Strategy Overview
- 18.3.3. Regeneron Pharmaceuticals Inc.
- 18.3.3.1. Overview
- 18.3.3.2. Product Portfolio
- 18.3.3.3. Sales Footprint
- 18.3.3.4. Strategy Overview
- 18.3.4. Allergan plc
- 18.3.4.1. Overview
- 18.3.4.2. Product Portfolio
- 18.3.4.3. Sales Footprint
- 18.3.4.4. Strategy Overview
- 18.3.5. Oxurion
- 18.3.5.1. Overview
- 18.3.5.2. Product Portfolio
- 18.3.5.3. Sales Footprint
- 18.3.5.4. Strategy Overview
- 18.3.6. Sirnaomics, Inc.
- 18.3.6.1. Overview
- 18.3.6.2. Product Portfolio
- 18.3.6.3. Sales Footprint
- 18.3.6.4. Strategy Overview
- 18.3.7. Genentech
- 18.3.7.1. Overview
- 18.3.7.2. Product Portfolio
- 18.3.7.3. Sales Footprint
- 18.3.7.4. Strategy Overview
- 18.3.8. Glycadia Pharmaceuticals
- 18.3.8.1. Overview
- 18.3.8.2. Product Portfolio
- 18.3.8.3. Sales Footprint
- 18.3.8.4. Strategy Overview
- 18.3.9. Alimera Sciences
- 18.3.9.1. Overview
- 18.3.9.2. Product Portfolio
- 18.3.9.3. Sales Footprint
- 18.3.9.4. Strategy Overview
- 18.3.10. Ampio Pharmaceuticals
- 18.3.10.1. Overview
- 18.3.10.2. Product Portfolio
- 18.3.10.3. Sales Footprint
- 18.3.10.4. Strategy Overview
- 18.3.11. BCN Peptides
- 18.3.11.1. Overview
- 18.3.11.2. Product Portfolio
- 18.3.11.3. Sales Footprint
- 18.3.11.4. Strategy Overview
- 18.3.12. Kowa Group
- 18.3.12.1. Overview
- 18.3.12.2. Product Portfolio
- 18.3.12.3. Sales Footprint
- 18.3.12.4. Strategy Overview
- 19. Assumptions and Acronyms Used
- 20. Research Methodology
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook